Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
CrossAmerica Partners LP Unit | CAPL | 20. nov 2024 | 19.94 | -0.50 |
CrossFirst Bankshares | CFB | 20. nov 2024 | 17.23 | +0.88 |
CrowdStrike A | CRWD | 20. nov 2024 | 350.15 | -0.89 |
Crown Castle | CCI | 20. nov 2024 | 104.37 | -0.10 |
Crown Crafts | CRWS | 20. nov 2024 | 4.52 | +0.44 |
Crown ElectroKinetics | CRKN | 20. nov 2024 | 0.79 | -5.34 |
Crown Holdings | CCK | 20. nov 2024 | 90.28 | +0.83 |
Crown LNG | CGBS | 20. nov 2024 | 0.34 | -2.54 |
Cryo-Cell International | CCEL | 20. nov 2024 | 7.87 | -2.11 |
CryoPort | CYRX | 20. nov 2024 | 6.57 | -5.26 |
CS Disco | LAW | 20. nov 2024 | 5.44 | 0.00 |
CSG Systems International | CSGS | 20. nov 2024 | 54.48 | +0.48 |
CSP | CSPI | 20. nov 2024 | 13.57 | +4.14 |
CSW Industrials | CSWI | 20. nov 2024 | 412.03 | -1.07 |
CSX | CSX | 20. nov 2024 | 34.57 | -0.09 |
CTO Realty Growth | CTO | 20. nov 2024 | 19.47 | -0.87 |
CTO Realty Growth A Pref | CTO-A | 20. nov 2024 | 23.80 | -0.71 |
CTS | CTS | 20. nov 2024 | 52.75 | +0.73 |
CubeSmart | CUBE | 20. nov 2024 | 48.31 | -1.37 |
Cue Biopharma | CUE | 20. nov 2024 | 1.09 | +0.93 |
Cullen Frost Bankers B Pref | CFR-B | 20. nov 2024 | 19.33 | -1.01 |
Cullen/Frost Bankers | CFR | 20. nov 2024 | 137.79 | -0.03 |
Cullinan Therapeutics | CGEM | 20. nov 2024 | 12.58 | -3.97 |
Cullman Bancorp | CULL | 20. nov 2024 | 9.71 | 0.00 |
Culp | CULP | 20. nov 2024 | 4.96 | +0.20 |
Cumberland Pharmaceuticals | CPIX | 20. nov 2024 | 1.09 | -1.80 |
Cummins | CMI | 20. nov 2024 | 360.95 | -0.25 |
Cumulus Media A | CMLS | 20. nov 2024 | 0.73 | -5.08 |
Curbline Properties | CURB | 20. nov 2024 | 23.87 | 0.00 |
Curevac N.V. | CVAC | 20. nov 2024 | 2.49 | -0.40 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.